← Home / INCYTE CORPORATION (INCY)
Stock Analysis
INCYTE CORPORATION (INCY)
INCY
INCY · Market data
119.52 -2.82%
Track INCY in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when INCY price is:
52W Range Position
81%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-08-02 16:45 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 129.93. Holding above 111.52 keeps the current thesis intact.
⚖️
✓
Fundamentals
Strong / Positive
✓
Price Structure
Constructive
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
111.52
↗
Break Above
Confirmation improves above resistance.
129.93
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 111.52
Recent Company Events
SEC VERIFIED
Latest material filings
JUL
28
●
Financial Results
HIGH
INCY reports financial results
On July 28, 2026 , Incyte Corporation issued a press release announcing financial results for its second fiscal quarter ended June 30, 2026.
8-K Filing • SEC EDGAR
JUL
6
◆
M&A
HIGH
Incyte Completes Acquisition of Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding its Hematology Portfolio
Incyte (Nasdaq:INCY) announced today it has completed its acquisition of Vega Therapeutics, Inc., a wholly owned subsidiary of Star Therapeutics LLC.
8-K Filing • SEC EDGAR
JUN
22
●
Legal / Regulatory
HIGH
INCY legal or regulatory update
Incyte Corporation (the “Company”) today announced that it has reached an agreement with the Centers for Medicare & Medicaid Services (“CMS”) to resolve the Company’s litigation related to the application of Medicaid rebate rules to Opzelura ® (ruxolitinib) cream.
8-K Filing • SEC EDGAR
What's Driving INCY?
📈 Technical recovery is improving
Momentum is Neutral. Watch 129.93 for confirmation and 111.52 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 111.52 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Technical Setup Active
✓
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Pattern
Triangle Compression / SYM / DOWN
State
Back Inside
Trigger
115.58
Risk / Invalid
103.75
Compression
94%
RSI(14)
55.2
◎
How to read this setup
Active technical structure detected. Use the chart overlays, support, resistance and invalidation levels to manage confirmation and risk.
Price Chart
INCY — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-31
Fair
Fair valuation
Strong quality metrics make the valuation look balanced rather than simply cheap.
Market Cap
$23.9B
Company size
EV
$40.3B
Debt-adjusted value
P/E
16.7
Low multiple
P/S
4.5
Balanced
P/B
4.3
Balanced
EV/Sales
7.5
Balanced
EV/EBIT
25.0
Reasonable
P/FCF
15.8
Low multiple
FCF Yield
6.33%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Improving financial execution
Growth, profitability, cash flow and balance sheet quality remain broadly supportive.
↗
Revenue Growth
Strong
●
Profitability
Positive
≈
Cash Flow
Healthy
⚖
Balance Sheet
Strong
💵 Revenue
1.27B
↗ Strong
📈 Net Income
303.33M
↗ Positive
🧮 EPS (Basic)
1.52
↗ Positive
INCYTE CORPORATION
Related Opportunities